Effect of Transcutaneous Electrical Stimulation on Constipation
Effects of Transcutaneous Electrical Nerve Stimulation on Constipation in Children With Cerebral Palsy
1 other identifier
interventional
30
1 country
1
Brief Summary
Cerebral palsy (CP) is a group of non-progressive neurological disorders that affect body movement, muscle coordination, and posture .It is caused by damage in developing brain, usually before or during birth, but can also occur during early childhood. They may include muscle stiffness or floppiness, abnormal reflexes, impaired coordination, difficulty with fine motor skills, speech and swallowing difficulties, involuntary movements, problems with balance and posture, and intellectual or developmental disabilities. Constipation is a common gastrointestinal issue in children with cerebral palsy (CP) due to reduced muscle tone, impaired coordination, limited mobility, and side effects of certain drugs like antispasmodics or anti-epileptics. Transcutaneous electrical nerve stimulation (TENS) is a non-invasive therapy. Usually, TENS is commonly used as pain management modality, its role in treating constipation in children with cerebral palsy is still being explored. Research on the use of TENS for constipation in children with cerebral palsy is limited, and most studies have focused on constipation in adults or individuals without CP. However, some studies have investigated the effects of TENS on gastrointestinal function in children with CP, including constipation. This study was Randomized Controlled Trial with random sampling technique. Study was conducted in DHQ Hospital, Hafizabad from July 2023 to December 2023 on 34 children with cerebral palsy with constipation having age from 1 to 6 years according to inclusion and exclusion criteria. After recruitment, it was divided into two Groups. Baseline treatment was provided to control group while TENS will be used in other experimental group. TENS was applied on abdominal area for 20 minutes along with baseline treatment. Record pre and post session history of patient defecation frequency per week, abdominal pain or discomfort, and type of stool via using Rome-IV criteria, Bristol Stool Scale, Constipation Assessment scale and Gross Motor Function Classification System before and after treatment. Data Analyses was based on statistical parameters and comparison performed before and after application of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 26, 2023
CompletedFirst Posted
Study publicly available on registry
January 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 5, 2024
CompletedJune 13, 2024
June 1, 2024
2 months
December 26, 2023
June 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Bristol Stool Scale(BSS)
BSS is a diagnostic tool which is designed to classify the form of human feces into seven categories. Types 1 and 2 indicates constipation, type 3,4 and 5 being the ideal stools, not containing excess liquid, type; 6 and 7 indicates lack of dietary fiber,it indicates diarrhea
4 weeks
Romes-IV criteria
Recurrent abdominal pain on average at least 1 day/week in the last 3 months, associated with two or more of the following criteria Related to defecation Associated with a change in frequency of stool Associated with a change in form (appearance) of stool Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis
4 weeks
Constipation Assessments Scale (CAS)
Constipation Assessments Scale is a valid and reliable tool consisting of 8 self-reported items investigating the presence and severity of constipation in both children and adults. The scoring is provided by a 3-point rating scale indicating 0= as no constipation, 1 = as some problem, and 2= as severe problem. Total score ranges between 0 (no constipation) and 16 (severe constipation). Although CAS is a self-reported questionnaire, parents or caregivers were asked to answer the questions for those children who were unable to read and/or comprehend the scale because of their age.
4 weeks
Visual Analogue Scale(VAS)
VAS is most frequently used to evaluate the degree of pain, it has also been used to assess the burden and the severity of musculoskeletal disorders in various studies. Satisfaction of treatment was measured on a 10-cm scale. Both the children and the caregivers or parents were asked to rate their overall satisfaction between 0(indicating no satisfaction) and 10 (most satisfied).Visual Analogue Scale use is shown to be a valid and reliable assessment method for use in children. The reliability of VAS is .60 to .79 for usual pain and .88 for worst pain. Gross Motor Functional Classification System(GMFS)(7, 8) The reliability of GMFS is 0.93.It provides an objective classification of the patterns of motor disability in children with CP(20).The GMFCS is a 5 level classification that differentiates children with cerebral palsy based on the child's current gross motor abilities, limitations in gross motor function, and need for assistive technology and wheeled mobility.
4 weeks
Study Arms (2)
Experimental Group
EXPERIMENTALTENS was applied on abdomen along with baseline movements and stretches were given to experimental group.
Control Group
ACTIVE COMPARATORBaseline movements and stretches were given to control group
Interventions
Defecation frequency per week, abdominal pain or discomfort, type of stool, severity of the constipation, frequency and consistency of stool, were measured before the commencement of treatment by using Romes-IV criteria, Visual Analogue Scale (VAS),Bristol Stool Scale (BSS),Gross Motor Functional Classification System (GMFCS) and Constipation Assessment Scale(CAS).After taking the measurements apply TENS on abdomen i.e. on the lower gastrointestinal tract, placed two skin electrodes of TENS on the abdomen lateral to the umbilicus and other two electrodes on back side at T9-L2 level for a month (20 minutes per session and 3 times a week) along with baseline treatment in which general movements were performed. After the completion of treatment same tools were used to re-assess the defecation frequency per week, abdominal pain or discomfort, type of stool, and severity of the constipation, frequency and consistency of stool for the measurement of final reading(Pre and post-treatment).
In control group, after the recruitment of participants according to the inclusion criteria. The baseline measurement were recorded by using Romes-IV criteria, Visual Analogue Scale (VAS), Bristol Stool Scale (BSS),Gross Motor Functional Classification System (GMFCS) and Constipation Assessment Scale(CAS). The baseline treatment is given in which general movements were performed i.e. Double knee-to-chest movement, sitting, standing, rolling as well as stretching of calf, hamstrings, adductors of both sides. Again assess the patient severity of constipation, frequency and consistency of stool, abdominal pain and functional status after the end of last session of the treatment(Pre and Post-treatment method).
Eligibility Criteria
You may qualify if:
- age 1-6years
- Constipation from at least a month
- Labelled constipation according to the Rome IV criteria
- History of severe stool retention
- History of difficult and painful bowel movements
- History of large diameter stool
- Presence large fecal masses in rectum
- In toilet trained children history of obstructing the toilet at least once a week after use of toilet
You may not qualify if:
- History of indigestion
- History of metabolic disorders
- Hirschsprung's disease
- hypothyroidism
- cystic fibrosis
- previous abdominal or anal sphincter surgery history
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Riphah International University
Lahore, Punjab Province, 54000, Pakistan
Related Publications (2)
Soumena RZ, Darma A, Ranuh RG, Gunawan PI, Sumitro KR, Sudarmo SM. Efficacy of transcutaneous electrical nerve stimulation on slow transit constipation in children with cerebral palsy. Bali Medical Journal. 2023;12(1):192-6.
BACKGROUNDAwan WA, Masood T. Role Of Stretching Exercises In The Management Of Constipation In Spastic Cerebral Palsy. J Ayub Med Coll Abbottabad. 2016 Oct-Dec;28(4):798-801.
PMID: 28586619BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ushna Yalnaz, MS*
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 26, 2023
First Posted
January 10, 2024
Study Start
December 1, 2023
Primary Completion
February 5, 2024
Study Completion
February 5, 2024
Last Updated
June 13, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share